Literature DB >> 24553583

A commentary on concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis.

Terence C Chua1, David L Morris1.   

Abstract

Entities:  

Year:  2014        PMID： 24553583     DOI： 10.1038/jhg.2014.11

Source DB:  PubMed          Journal:  J Hum Genet        ISSN： 1434-5161            Impact factor:   3.172


× No keyword cloud information.
  6 in total

1.  Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.

Authors:  C H Lieu; L A Lambert; R A Wolff; C Eng; N Zhang; S Wen; S Rafeeq; M Taggart; K Fournier; R Royal; P Mansfield; M J Overman
Journal:  Ann Oncol       Date:  2011-06-08       Impact factor: 32.976

2.  Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Terence C Chua; Brendan J Moran; Paul H Sugarbaker; Edward A Levine; Olivier Glehen; François N Gilly; Dario Baratti; Marcello Deraco; Dominique Elias; Armando Sardi; Winston Liauw; Tristan D Yan; Pedro Barrios; Alberto Gómez Portilla; Ignace H J T de Hingh; Wim P Ceelen; Joerg O Pelz; Pompiliu Piso; Santiago González-Moreno; Kurt Van Der Speeten; David L Morris
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

3.  Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.

Authors:  Robert F Bradley; John H Stewart; Gregory B Russell; Edward A Levine; Kim R Geisinger
Journal:  Am J Surg Pathol       Date:  2006-05       Impact factor: 6.394

Review 4.  New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?

Authors:  Paul H Sugarbaker
Journal:  Lancet Oncol       Date:  2006-01       Impact factor: 41.316

5.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".

Authors:  B M Ronnett; C M Zahn; R J Kurman; M E Kass; P H Sugarbaker; B M Shmookler
Journal:  Am J Surg Pathol       Date:  1995-12       Impact factor: 6.394

6.  Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis.

Authors:  Terence T Sio; Aaron S Mansfield; Travis E Grotz; Rondell P Graham; Julian R Molina; Florencia G Que; Robert C Miller
Journal:  J Hum Genet       Date:  2013-12-26       Impact factor: 3.172
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.